Skip to content
Trial Eligibility
Menu

Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer's Disease and Other Dementias 2.0

NCT05950607

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The goal of this pragmatic cluster randomized clinical trial is to compare management of suspected infection in nursing home residents with dementia The main questions it aims to answer whether residents with dementia in nursing homes randomized to use a multicomponent intervention to optimize suspected infection management ( versus usual care) use less antibiotics and fewer burdensome interventions.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Dementia
  • Alzheimer Disease
  • Infections

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
60 to 106 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Hebrew SeniorLife
Last updated on ClinicalTrials.gov
January 6, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Massachusetts · 1

  • Hebrew SeniorLife · Boston, MA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.